Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
2020
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
2020
New frontiers in liver resection for hepatocellular carcinoma
2020
Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C
2009
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
2012
Targeting cancer stem cell pathways for cancer therapy
2020
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
2015
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma
2015
Laparoscopic Resection for Rectal Cancer: A Review
2009
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
2015
Acute-on chronic liver failure
2012
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Hepatocellular carcinoma
2012 Standout
Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list
2013
Hepatocellular carcinoma
2021 Standout
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
2010
Acute-on-chronic liver failure in cirrhosis
2016
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
2015
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
2014
Comparative Short-term Benefits of Laparoscopic Liver Resection
2015
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Acute Pancreatitis
2016 Standout
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
2021
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
2013
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Acute-on-chronic liver failure: terminology, mechanisms and management
2016
Role of antiviral treatment for HCC prevention
2014
Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
2015
Non-alcoholic fatty liver disease and liver transplantation
2016
Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features
2017
Timing of Cholecystectomy After Mild Biliary Pancreatitis
2012
Then and now: The progress in hepatitis B treatment over the past 20 years
2014
Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients
2018
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Hepatitis B virus infection
2018
Acute-on-chronic Liver Failure
2016
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
2009
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma
2011
Mycobacterial infections in solid organ transplant recipients
2014
The option of HBIG-free prophylaxis against recurrent HBV
2012
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Outcome After Liver Transplantation
2010
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
2021
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
2015
Hepatocellular carcinoma
2022 Standout
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
2018
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
2013
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma
2019
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
2017
<p>Taiwan’s National Health Insurance Research Database: past and future</p>
2019 Standout
Does the preoperative alpha‐fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma
2014
Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Recent Advances in the Prevention of Hepatocellular Carcinoma Recurrence
2014
Dexamethasone in outcome of patients with hepatitis B virus‐related acute‐on‐chronic liver failure
2013
High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?
2013
Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis
2021
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma
2016
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
2013
Management of people with early- or very early-stage hepatocellular carcinoma
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
2012
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Management of patients with hepatitis B in special populations
2015
Indocyanine green‐fluorescent imaging of hepatocellular carcinoma during laparoscopic hepatectomy: An initial experience
2010
Works of Albert Chan being referenced
Liver transplantation for acute-on-chronic liver failure
2009
Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma
2013
Treatment strategy for recurrent hepatocellular carcinoma: Salvage transplantation, repeated resection, or radiofrequency ablation?
2013
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
2018
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
2011
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong
2019
11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective
2013
A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation
2015
Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses
2019
Implications for management of Mycobacterium tuberculosis infection in adult‐to‐adult live donor liver transplantation
2006
Laparoscopic Liver Resection for Hepatocellular Carcinoma
2010
Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
2013
The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis
2012
Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma
2012
Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening
2008
Criteria for liver transplantation in ACLF and outcome
2014
Liver Transplantation for Combined Hepatocellular Cholangiocarcinoma
2007
The Role of Cholecystectomy in Reducing Recurrent Gallstone Pancreatitis
2004
Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS
2016
Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5–8 cm
2014
Can positron emission tomography with the dual tracers [11C]acetate and [18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
2011
Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma
2013
Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
2012
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation
2012
Impact of Antiviral Therapy on the Survival of Patients After Major Hepatectomy for Hepatitis B Virus–Related Hepatocellular Carcinoma
2011
Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer
2008
Hepatocellular Carcinoma: Surveillance CT Schedule after Hepatectomy Based on Risk Stratification
2014
Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion
2011
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
2015
Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome
2013
Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years
2017
Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells
2017
Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis
2016
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
2017
Excellent outcomes of liver transplantation using severely steatotic grafts from brain‐dead donors
2015
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
2021
Survival Analysis of Re‐resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
2011
Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single‐center experience
2014